FMP

FMP

Enter

CRL - Charles River Labora...

photo-url-https://images.financialmodelingprep.com/symbol/CRL.png

Charles River Laboratories International, Inc.

CRL

NYSE

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

171.04 USD

4.11 (2.4%)

CRL Financial Statements

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Total Revenue

1B

1.01B

1.03B

1.01B

Cost of Revenue

718.3M

660.74M

690.65M

691.37M

Gross Profit

284.24M

349.02M

335.46M

320.19M

Operating Expenses

451.93M

199.21M

165.85M

177.22M

Research and Development

0

0

0

0

Selling, General & Administrative Expenses

195.71M

199.21M

165.85M

177.22M

Selling & Marketing Expenses

0

0

0

0

General & Administrative Expenses

0

0

0

0

Other Expenses

256.22M

0

-2.24M

5.83M

Operating Income

-167.69M

117.41M

169.61M

142.98M

Total Other Income/Expenses Net

-49.1M

-26.16M

-32M

-43.97M

Income Before Tax

-216.79M

91.24M

119.65M

99.01M

Income Tax

-3.04M

20.95M

25.39M

24.53M

Net Income

-213.75M

68.68M

89.99M

67.33M

Basic EPS

-4.18

1.34

1.75

1.42

EPS Diluted

-4.18

1.33

1.74

1.41

Basic Average Shares

51.14M

51.39M

51.55M

51.44M

Diluted Average Shares

51.14M

51.58M

51.85M

51.84M

EBITDA

-86.45M

209.72M

238.5M

219.37M

Retained Earning Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Retained Earnings (Previous Year)

2.12B

2.05B

1.96B

1.89B

Net Income

-213.75M

68.68M

89.99M

67.33M

Stock Repurchases

-124k

-100.79M

-8.91M

-9.35M

Dividend Paid

0

0

0

0

Retained Earnings

1.81B

2.12B

2.05B

1.96B

Other Distributions

-310.86M

-31.51M

84.87M

63.21M

PPE Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Gross PPE

2.02B

2.03B

2B

2B

Annual Depreciation

102.1M

88.2M

86.08M

85.36M

Capital Expenditure

-75.62M

-38.72M

-39.49M

-79.14M

Net PPE

1.99B

1.98B

1.95B

2B

Intangible and Goodwill Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Acquisitions and Adjustments

-277.98M

44.9M

9.45M

-24.8M

Goodwill (Previous Year)

3.12B

3.08B

3.07B

3.1B

Goodwill

2.85B

3.12B

3.08B

3.07B

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep